50
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Dentistry and HIV/AIDS related stigma

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          OBJECTIVE

          To analyze HIV/AIDS positive individual’s perception and attitudes regarding dental services.

          METHODS

          One hundred and thirty-four subjects (30.0% of women and 70.0% of men) from Nuevo León, Mexico, took part in the study (2014). They filled out structured, analytical, self-administered, anonymous questionnaires. Besides the sociodemographic variables, the perception regarding public and private dental services and related professionals was evaluated, as well as the perceived stigma associated with HIV/AIDS, through a Likert-type scale. The statistical evaluation included a factorial and a non-hierarchical cluster analysis.

          RESULTS

          Social inequalities were found regarding the search for public and private dental professionals and services. Most subjects reported omitting their HIV serodiagnosis and agreed that dentists must be trained and qualified to treat patients with HIV/AIDS. The factorial analysis revealed two elements: experiences of stigma and discrimination in dental appointments and feelings of concern regarding the attitudes of professionals or their teams concerning patients’ HIV serodiagnosis. The cluster analysis identified three groups: users who have not experienced stigma or discrimination (85.0%); the ones who have not had those experiences, but feel somewhat concerned (12.7%); and the ones who underwent stigma and discrimination and feel concerned (2.3%).

          CONCLUSIONS

          We observed a low percentage of stigma and discrimination in dental appointments; however, most HIV/AIDS patients do not reveal their serodiagnosis to dentists out of fear of being rejected. Such fact implies a workplace hazard to dental professionals, but especially to the very own health of HIV/AIDS patients, as dentists will not be able to provide them a proper clinical and pharmaceutical treatment.

          Related collections

          Most cited references21

          • Record: found
          • Abstract: not found
          • Article: not found

          A technique for the measturement of attittudes

            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Determination and quantification of content validity.

            M Lynn (1986)
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              From conceptualizing to measuring HIV stigma: a review of HIV stigma mechanism measures.

              Recent analyses suggest that lack of clarity in the conceptualization and measurement of HIV stigma at an individual level is a significant barrier to HIV prevention and treatment efforts. In order to address this concern, we articulate a new framework designed to aid in clarifying the conceptualization and measurement of HIV stigma among individuals. The HIV Stigma Framework explores how the stigma of HIV elicits a series of stigma mechanisms, which in turn lead to deleterious outcomes for HIV uninfected and infected people. We then apply this framework to review measures developed to gauge the effect of HIV stigma since the beginning of the epidemic. Finally, we emphasize the utility of using three questions to guide future HIV stigma research: who is affected by, how are they affected by, and what are the outcomes of HIV stigma?
                Bookmark

                Author and article information

                Journal
                Rev Saude Publica
                Rev Saude Publica
                rsp
                Revista de Saúde Pública
                Faculdade de Saúde Pública da Universidade de São Paulo
                0034-8910
                1518-8787
                19 October 2015
                2015
                : 49
                : 79
                Affiliations
                [I ]Programa de Posgrado en Biotecnología. Grupo de investigación en Biofármacos e Ingeniería Biofarmacéutica. Escuela Nacional de Posgrado en Ciencias e Ingeniería. Instituto Tecnológico de Monterrey. Monterrey, México
                [II ]Programa de Posgrado en Odontología. Escuela de Doctorado. Universitat Internacional de Catalunya. Barcelona, España
                [III ]Departamento de Ciencias Básicas. Escuela Nacional de Medicina. Instituto Tecnológico de Monterrey. Monterrey, México
                [IV ]Programa de Pregrado Médico Cirujano Odontólogo. Escuela de Biotecnología y Ciencias de la Salud. Instituto Tecnológico de Monterrey. Monterrey, México
                [I ] Programa de Posgrado en Biotecnología. Grupo de investigación en Biofármacos e Ingeniería Biofarmacéutica. Escuela Nacional de Posgrado en Ciencias e Ingeniería. Instituto Tecnológico de Monterrey.Monterrey, México
                [II ] Programa de Posgrado en Odontología. Escuela de Doctorado. Universitat Internacional de Catalunya. Barcelona, España
                [III ] Departamento de Ciencias Básicas. Escuela Nacional de Medicina. Instituto Tecnológico de Monterrey. Monterrey, México
                [IV ] Programa de Pregrado Médico Cirujano Odontólogo. Escuela de Biotecnología y Ciencias de la Salud. Instituto Tecnológico de Monterrey. Monterrey, México
                Author notes
                Correspondence: Jesús Eduardo Elizondo Grupo de investigación en Biofármacos e Ingeniería Biofarmacéutica Escuela Nacional de Posgrado en Ciencias e Ingeniería Instituto Tecnológico de Monterrey Avenida Eugenio Garza Sada 2501 Sur Colonia Tecnológico, Monterrey, Nuevo León 64849 CP, México E-mail: je.elizondo.phd.mty@ 123456itesm.mx

                CONTRIBUTIONS FROM THE AUTHORS

                Elizondo JE and Treviño AC conceived, planned, and executed (conducted) the fieldwork. Elizondo JE statistically analyzed the data, interpreted the results, and wrote the article. Violant D facilitated, supervised, gave technical advice, offered ideas to interpret results, revised, edited, and approved the final version of the manuscript.

                The authors declare no conflict of interest.

                Correspondencia: Jesús Eduardo Elizondo Grupo de investigación en Biofármacos e Ingeniería Biofarmacéutica Escuela Nacional de Posgrado en Ciencias e Ingeniería Instituto Tecnológico de Monterrey Avenida Eugenio Garza Sada 2501 Sur Colonia Tecnológico, Monterrey, Nuevo León 64849 CP, México E-mail: je.elizondo.phd.mty@itesm.mx

                CONTRIBUCIONES DE LOS AUTORES

                Elizondo JE y Treviño AC, concibieron, diseñaron y ejecutaron (realizaron el trabajo de campo). Elizondo JE realizó el análisis estadístico de los resultados, su interpretación, redactó y es responsable del artículo. Violant D facilitó, supervisó, asesoró técnicamente, aportó ideas para la interpretación de los resultados, revisó, editó y aprobó la versión final del manuscrito.

                Los autores declaran no tener conflicto de intereses.

                Article
                S0034-8910.2015049005877
                10.1590/S0034-8910.2015049005877
                4617436
                a4cc390f-3e3c-4a16-9b01-9496d438b19d

                This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

                History
                : 26 September 2014
                : 31 January 2015
                Page count
                Figures: 0, Tables: 10, Equations: 0, References: 25, Pages: 1
                Funding
                Funded by: Consejo Nacional de Ciencia y Tecnologia
                Award ID: Protocol 290638 / CVU 330673
                Funded by: Centro Nacional para la prevención y el Control del VIH/SIDA
                Award ID: Proj. 2014-0137
                Funded by: Centro Nacional para la prevención y el Control del VIH/SIDA
                Award ID: Proj. 2014-0171
                Funded by: Biopharmaceuticals and Biopharmaceutical Engineering
                Award ID: 0821B01002
                Research supported by the Consejo Nacional de Ciencia y Tecnologia (CONACyT – Protocol 290638 / CVU 330673), by the (Centro Nacional para la prevención y el Control del VIH/SIDA (Censida Proj. 2014-0137 and Proj. 2014-0171), and by the research group on Biopharmaceuticals and Biopharmaceutical Engineering (0821B01002) at the National Postgraduate School in Sciences and Engineering of Instituto Tecnologico y de Estudios Superiores de Monterrey.
                Categories
                Articles

                hiv long-term survivors,dental health services,health knowledge, attitudes, practice,prejudice,social discrimination,health inequalities,psychometrics,mexico,sobrevivientes de vih a largo plazo,servicios de salud dental,conocimientos, actitudes y práctica en salud,prejuicio,discriminación social,desigualdades en la salud,psicometría,méxico

                Comments

                Comment on this article